Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Periostin Promotes Cell Proliferation and Macrophage Polarization to Drive Repair after AKI.

Kormann R, Kavvadas P, Placier S, Vandermeersch S, Dorison A, Dussaule JC, Chadjichristos CE, Prakoura N, Chatziantoniou C.

J Am Soc Nephrol. 2019 Nov 5. pii: ASN.2019020113. doi: 10.1681/ASN.2019020113. [Epub ahead of print]

PMID:
31690575
2.

Novel Targets for Therapy of Renal Fibrosis.

Prakoura N, Hadchouel J, Chatziantoniou C.

J Histochem Cytochem. 2019 Sep;67(9):701-715. doi: 10.1369/0022155419849386. Epub 2019 May 22.

PMID:
31116064
3.

Connexin 43: a New Therapeutic Target Against Chronic Kidney Disease.

Prakoura N, Kavvadas P, Chadjichristos CE.

Cell Physiol Biochem. 2018;49(3):985. doi: 10.1159/000493230. Epub 2018 Sep 7. Review.

4.

The family of 14-3-3 proteins and specifically 14-3-3σ are up-regulated during the development of renal pathologies.

Rizou M, Frangou EA, Marineli F, Prakoura N, Zoidakis J, Gakiopoulou H, Liapis G, Kavvadas P, Chatziantoniou C, Makridakis M, Vlahou A, Boletis J, Vlahakos D, Goumenos D, Daphnis E, Iatrou C, Charonis AS.

J Cell Mol Med. 2018 Sep;22(9):4139-4149. doi: 10.1111/jcmm.13691. Epub 2018 Jun 28.

5.

Notch3 orchestrates epithelial and inflammatory responses to promote acute kidney injury.

Kavvadas P, Keuylian Z, Prakoura N, Placier S, Dorison A, Chadjichristos CE, Dussaule JC, Chatziantoniou C.

Kidney Int. 2018 Jul;94(1):126-138. doi: 10.1016/j.kint.2018.01.031. Epub 2018 May 8.

PMID:
29751972
6.

Periostin in kidney diseases.

Prakoura N, Chatziantoniou C.

Cell Mol Life Sci. 2017 Dec;74(23):4315-4320. doi: 10.1007/s00018-017-2650-6. Epub 2017 Sep 7. Review.

PMID:
28884334
7.

Decreased Expression of Connexin 43 Blunts the Progression of Experimental GN.

Kavvadas P, Abed A, Poulain C, Authier F, Labéjof LP, Calmont A, Afieri C, Prakoura N, Dussaule JC, Chatziantoniou C, Chadjichristos CE.

J Am Soc Nephrol. 2017 Oct;28(10):2915-2930. doi: 10.1681/ASN.2016111211. Epub 2017 Jun 30.

8.

Periostin and Discoidin Domain Receptor 1: New Biomarkers or Targets for Therapy of Renal Disease.

Prakoura N, Chatziantoniou C.

Front Med (Lausanne). 2017 May 9;4:52. doi: 10.3389/fmed.2017.00052. eCollection 2017. Review.

9.

NFκB-Induced Periostin Activates Integrin-β3 Signaling to Promote Renal Injury in GN.

Prakoura N, Kavvadas P, Kormann R, Dussaule JC, Chadjichristos CE, Chatziantoniou C.

J Am Soc Nephrol. 2017 May;28(5):1475-1490. doi: 10.1681/ASN.2016070709. Epub 2016 Dec 5.

10.

Nuclear receptor NR5A2 is involved in the calreticulin gene regulation during renal fibrosis.

Arvaniti E, Vakrakou A, Kaltezioti V, Stergiopoulos A, Prakoura N, Politis PK, Charonis A.

Biochim Biophys Acta. 2016 Sep;1862(9):1774-85. doi: 10.1016/j.bbadis.2016.06.013. Epub 2016 Jun 21.

11.

Epithelial calreticulin up-regulation promotes profibrotic responses and tubulointerstitial fibrosis development.

Prakoura N, Politis PK, Ihara Y, Michalak M, Charonis AS.

Am J Pathol. 2013 Nov;183(5):1474-1487. doi: 10.1016/j.ajpath.2013.07.014. Epub 2013 Sep 11.

PMID:
24035512
12.

Transgelin Up-Regulation in Obstructive Nephropathy.

Karagianni F, Prakoura N, Kaltsa G, Politis P, Arvaniti E, Kaltezioti V, Psarras S, Pagakis S, Katsimboulas M, Abed A, Chatziantoniou C, Charonis A.

PLoS One. 2013 Jun 26;8(6):e66887. doi: 10.1371/journal.pone.0066887. Print 2013.

13.

Renal fibrosis: insight from proteomics in animal models and human disease.

Klein J, Kavvadas P, Prakoura N, Karagianni F, Schanstra JP, Bascands JL, Charonis A.

Proteomics. 2011 Feb;11(4):805-15. doi: 10.1002/pmic.201000380. Epub 2011 Jan 13. Review. Erratum in: Proteomics. 2011 Jun;11(11):2359.

PMID:
21229585
14.

Cumulative contributions of weak DNA determinants to targeting the Drosophila dosage compensation complex.

Gilfillan GD, König C, Dahlsveen IK, Prakoura N, Straub T, Lamm R, Fauth T, Becker PB.

Nucleic Acids Res. 2007;35(11):3561-72. Epub 2007 May 5.

Supplemental Content

Loading ...
Support Center